Publication | Open Access
Longitudinal immune cell monitoring identified CD14++ CD16+ intermediate monocyte as a marker of relapse in patients with ANCA-associated vasculitis
27
Citations
35
References
2020
Year
Chronological changes in CD14<sup>++</sup> CD16<sup>+</sup> intermediate monocyte counts can be a marker of disease relapse in AAV patients.
| Year | Citations | |
|---|---|---|
Page 1
Page 1